Presentation on Patient Safety Measurement for visitors from Sweden in 2007Noel Eldridge
This presentation was put together on the special topic of measurement when a group from Sweden was visiting the Dept of Veterans Affairs National Center for Patient Safety to learn about patient safety improvement programs underway there. I remember some of the people listening resisting my main point that so far there was no good way to measure PS outcomes, but some good ways to measure important outcomes that are potential precursors to patient safety problems (like not getting X-rays verified in a timely way).
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan BaralMSMGF
MSMGF held the Civil Society Hearings Side Event,: Unfinished Business – Taking bolder action to address HIV among gay and bisexual men and other men who have sex with men, at the United Nations in New York City in close consultation with the Global Platform to Fast Track the HIV and Human Rights Responses Among Gay, Bisexual Men and Other Men Who Have Sex with Men (The Platform), and supported by UNAIDS, UNDP, OGAC/PEPFAR, and the Global Fund.
Presentation on Patient Safety Measurement for visitors from Sweden in 2007Noel Eldridge
This presentation was put together on the special topic of measurement when a group from Sweden was visiting the Dept of Veterans Affairs National Center for Patient Safety to learn about patient safety improvement programs underway there. I remember some of the people listening resisting my main point that so far there was no good way to measure PS outcomes, but some good ways to measure important outcomes that are potential precursors to patient safety problems (like not getting X-rays verified in a timely way).
HIv risks and vulnerabilities among Gay, Bisexuals and Others MSM, Stefan BaralMSMGF
MSMGF held the Civil Society Hearings Side Event,: Unfinished Business – Taking bolder action to address HIV among gay and bisexual men and other men who have sex with men, at the United Nations in New York City in close consultation with the Global Platform to Fast Track the HIV and Human Rights Responses Among Gay, Bisexual Men and Other Men Who Have Sex with Men (The Platform), and supported by UNAIDS, UNDP, OGAC/PEPFAR, and the Global Fund.
Presentation by Lenny Recupero, M.Ed.
Community Injury Prevention Coordinator
Division of Injury and Violence Prevention
Virginia Department of Health
A Snapshot of Fall-Related
Injuries Among Older Adults
Matthew Bishop: Rethinking What We Measure at Closing the Gap December 8 2015 socprog
Presentation by Matthew Bishop of The Economist, and member of the Board of Directors of the Social Progress Imperative, on the Social Progress Index at Closing the Gap in Palm Beach, Florida on December 8, 2015. The event brought together leaders from business, education, policy, foundations, and communities to explore solutions for a more inclusive economy.
Presentation at 2007 Meeting of Indian Health Service in San DiegoNoel Eldridge
This is based on Jim Bagian's "Why Bother" (about patient safety) presentation. Jim was invited but had a conflict so I wen to the national meeting of the Indian Health Service. I think this was maybe a 75 minute presentation. I added some things to make it personal to me like the Jimi Hendrix Experience slide and slide 81 on the "tissue issue" in VA that I helped resolve during my work on hand hygiene improvement. The audience also seemed to like my closing slide.
Slides on Diabetes in the South Focus on Prevention.2018hivlifeinfo
Learn how to overcome common barriers to diabetes prevention with this downloadable slideset.
Richard E. Pratley, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.16 MB
Released: October 23, 2018
Presentation by Lenny Recupero, M.Ed.
Community Injury Prevention Coordinator
Division of Injury and Violence Prevention
Virginia Department of Health
A Snapshot of Fall-Related
Injuries Among Older Adults
Matthew Bishop: Rethinking What We Measure at Closing the Gap December 8 2015 socprog
Presentation by Matthew Bishop of The Economist, and member of the Board of Directors of the Social Progress Imperative, on the Social Progress Index at Closing the Gap in Palm Beach, Florida on December 8, 2015. The event brought together leaders from business, education, policy, foundations, and communities to explore solutions for a more inclusive economy.
Presentation at 2007 Meeting of Indian Health Service in San DiegoNoel Eldridge
This is based on Jim Bagian's "Why Bother" (about patient safety) presentation. Jim was invited but had a conflict so I wen to the national meeting of the Indian Health Service. I think this was maybe a 75 minute presentation. I added some things to make it personal to me like the Jimi Hendrix Experience slide and slide 81 on the "tissue issue" in VA that I helped resolve during my work on hand hygiene improvement. The audience also seemed to like my closing slide.
Slides on Diabetes in the South Focus on Prevention.2018hivlifeinfo
Learn how to overcome common barriers to diabetes prevention with this downloadable slideset.
Richard E. Pratley, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.16 MB
Released: October 23, 2018
The development and implementation of two national beach safety signage standards (UK & Australia) and how they are leading to the creation of an international beach signage standard
Author: Steve Wills
(03-39)
AsNaSA Portugal’s proposal of an Action Plan for Teaching and Training in Water Safety Quality in the Portuguese Speaking Countries
Author: Fernando Martinho
(03-02)
Discussion session to consider and develop recommended strategies for an educational program, policies and environmental adaptions.
Author: Linda Quan and Elizabeth Bennett
(02-15)
Comparative Analysis of Educational Programmes (A Proposal of Innovation of Water Safety Educational Programme of Czech Red Cross in relation to the Standards of International Lifesaving Federation)
Author: Jana Novotna
(02-23)
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Are There Any Natural Remedies To Treat Syphilis.pdf
Estimating the Burden
1. Fatal and Nonfatal Drownings at Recreational Water Sites, U.S. Julie Gilchrist MD National Center for Injury Prevention and Control Centers for Disease Control and Prevention September, 2007
2.
3.
4.
5.
6.
7. Drowning * by Age *in recreational water settings Nonfatal Fatal Age (yrs) Estimate Percent Rate (95% CI) Number Percent Rate (95% CI) 0-4 2168 52.0 11.13 (3.56, 18.69) 442 13.1 2.28 (2.07, 2.50) 5-14 1058 25.3 2.58 (1.13, 4.02) 333 9.9 0.81 (0.72, 0.90) >=15 948 22.7 0.42 (0.20, 0.64) 2563 76.0 1.14 (1.10, 1.18) Unknown 34 1.0 TOTAL 4174 100.0 1.46 (0.77, 2.14) 3372 100.0 1.18 (1.14, 1.22) Data sources: National Electronic Injury Surveillance System All Injury Program for nonfatal injuries (2001-2002); National Vital Statistics System, National Center for Health Statistics for fatalities (2001).
8. Fatal Drowning Rates by Age, 2001 Fatal drowning data from National Vital Statistics System
9. Drowning by Sex *in recreational water settings Nonfatal Fatal Sex Estimate Percent Rate (95% CI) Number Percent Rate (95% CI) Male 2721 65.2 1.93 (1.16, 2.70) 2789 82.7 1.99 (1.92, 2.06) Female 1452 34.8 1.00 (0.27, 1.72) 583 17.3 0.40 (0.37, 0.43) Data sources: National Electronic Injury Surveillance System All Injury Program for nonfatal injuries (2001-2002); National Vital Statistics System, National Center for Health Statistics for fatalities (2001).
10. Fatal Drownings by Sex, 1999-2004 Fatal drowning data from National Vital Statistics System
11. Drowning by Location *in recreational water settings Nonfatal Fatal Location Estimate Percent Rate (95% CI) Number Percent Rate (95% CI) Pool 2751 65.9 0.96 (0.40, 1.51) 596 17.7 0.21 (0.19, 0.23) Natural water 909 21.8 0.32 (0.14, 0.49) 1467 43.5 0.51 (0.49, 0.54) Unspecified 513 12.3 1309 38.8 Data sources: National Electronic Injury Surveillance System All Injury Program for nonfatal injuries (2001-2002); National Vital Statistics System, National Center for Health Statistics for fatalities (2001).
12. Fatal Drowning Rates by Age Group & Location, 2001 Fatal drowning data from National Vital Statistics System
13. Pool Drowning Rates by Age Group & Race, 1999-2004 (rate per 100,000) Fatal drowning data from National Vital Statistics System
14. Natural Water Drowning Rates by Age Group & Race, 1999-2004 Fatal drowning data from National Vital Statistics System
17. Nonfatal Drowning by Disposition *in recreational water settings Nonfatal Disposition Estimate Percent Rate (95% CI) Treated and Released 1925 46.1 0.67 (0.29, 1.05) Hospitalized or Transferred 2233 53.5 0.78 (0.44, 1.12) Other/Unknown 16 0.4 -- Data source: National Electronic Injury Surveillance System All Injury Program for nonfatal injuries (2001-2002)
18. Injury Pyramid Death Hospitalization Emergency Department Outpatient Elsewhere or untreated All Unintentional Injuries Drowning 112,012 1,640,370 25,516,364 58,381,000 ? 3372 2212 1962 ~0 ~0